Inventor · disambiguated record
Emily Hanan
Also filed as: HANAN EMILY · HANAN EMILY J
17 granted patents·18 pending applications·118 citations·filing 2010–2025
93Inventor score
Top patents by PatentIndex Score
35 records- 0196US9650393B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 16, 2017·20 cites·23 claims
- 0294US10851091B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2018·Granted Dec 1, 2020·5 cites·3 claims
- 0393US11760753B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2020·Granted Sep 19, 2023·2 cites·17 claims
- 0492US10112932B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Granted Oct 30, 2018·8 cites·9 claims
- 0589US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 0689US2025197386A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0788US2025326745A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0887US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0987US8637526B2Pyrazolopyrimidine JAK inhibitor compounds and methodsBLANEY JEFFREY·Filed 2011·Granted Jan 28, 2014·17 cites·18 claims
- 1086US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 1186US2024199594A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1285US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1384US9951064B2Azaindazole compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2016·Granted Apr 24, 2018·5 cites·15 claims
- 1482US8623889B2Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereofLYSSIKATOS JOSEPH P·Filed 2011·Granted Jan 7, 2014·7 cites·24 claims
- 1580US9643980B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 9, 2017·3 cites·21 claims
- 1677US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1771US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1870US11649241B2Pyrazolochlorophenyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted May 16, 2023·0 cites·4 claims
- 1970US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 2068US2023133817A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2168US2023133667A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2264US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 2363US2017210733A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2457US2014107099A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2556US9206175B2Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereofGENENTECH INC·Filed 2013·Granted Dec 8, 2015·0 cites·22 claims
- 2655US12358951B2Cyclic peptide antibioticsGENENTECH INC·Filed 2021·Granted Jul 15, 2025·0 cites·22 claims
- 2754US2021198316A9Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2854US2020002346A1Pyrazolochlorophenyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2954US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3052US2018327367A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3150US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
- 3250US2016244456A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3348US2016060262A1Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses ThereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3447US11279735B2Cyclic peptide antibioticsGENENTECH INC·Filed 2020·Granted Mar 22, 2022·0 cites·28 claims
- 3543US2022135622A1Antibacterial peptides and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →